Literature DB >> 1535047

Inhibition of gustatory rhinorrhoea by intranasal ipratropium bromide.

N B Choudry, A J Harrison, R W Fuller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1535047     DOI： 10.1007/bf00314871

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  6 in total

1.  Intranasal ipratropium: a new treatment for perennial rhinitis.

Authors:  P Borum; N Mygind; F Schultz Larsen
Journal:  Clin Otolaryngol Allied Sci       Date:  1979-12

Review 2.  Drug treatment for nasal allergy.

Authors:  R J Davies; S Ollier; D R Cundell
Journal:  Clin Exp Allergy       Date:  1989-09       Impact factor: 5.018

3.  The mechanisms involved in onset of allergic manifestations in the nose.

Authors:  A Konno; K Togawa; T Fujiwara
Journal:  Eur J Respir Dis Suppl       Date:  1983

4.  Ipratropium treatment for rhinorrhoea in patients with perennial rhinitis. An open follow-up study of efficacy and safety.

Authors:  F Schultz Larsen; N Mygind; F S Larsen
Journal:  Clin Otolaryngol Allied Sci       Date:  1983-08

5.  Gustatory rhinitis: a syndrome of food-induced rhinorrhea.

Authors:  G Raphael; M H Raphael; M Kaliner
Journal:  J Allergy Clin Immunol       Date:  1989-01       Impact factor: 10.793

6.  Cold air-induced rhinorrhea and high-dose ipratropium.

Authors:  B Ostberg; B Winther; N Mygind
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1987-02
  6 in total
  3 in total

1.  Importance of placebo effect in cough clinical trials.

Authors:  Ron Eccles
Journal:  Lung       Date:  2009-09-16       Impact factor: 2.584

2.  Cough reflex and oral chemesthesis induced by capsaicin and capsiate in healthy never-smokers.

Authors:  Miyako Yamasaki; Satoru Ebihara; Takae Ebihara; Shannon Freeman; Shinsuke Yamanda; Masanori Asada; Motoki Yoshida; Hiroyuki Arai
Journal:  Cough       Date:  2007-10-31

Review 3.  The Powerful Placebo Effect in Cough: Relevance to Treatment and Clinical Trials.

Authors:  Ron Eccles
Journal:  Lung       Date:  2019-12-13       Impact factor: 2.584
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.